Priser
Platform
Blog
Om os
Download
Formosa Laboratories
Formosa Laboratories
Taiwan Stock Exchange
0

Om

Formosa Laboratories Inc. is a leading company in the pharmaceutical and chemical manufacturing industry, headquartered in Taiwan. It specializes in the production of active pharmaceutical ingredients (APIs) and has developed a diverse portfolio of health and wellness products. The company supports sectors ranging from healthcare to cosmetics by ensuring high standards of quality and compliance with international regulatory requirements. Formosa Laboratories is known for leveraging advanced technologies and innovative processes to enhance production efficiency and meet the growing demand from global markets. Its commitment to research and development drives its ability to offer tailored solutions for complex pharmaceutical formulations. With an established presence in the middle of the pharmaceutical supply chain, Formosa Laboratories plays a crucial role in securing essential medications' availability and consistency worldwide. The company's focus on sustainability and continuous improvement further underlines its significance in the global pharmaceutical industry.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I FORMOSA LABORATORIES MED ENDAVU: Køb Formosa Laboratories ($4746) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Formosa Laboratories, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

Ticker4746
Land
Taiwan
Hjemmesideformosalab.com
SektorSundhed
IndustriLægemiddelproducenter - Specialitet og generisk

Udbytter

1,98TWD
'18
0,5TWD
'19
2TWD
'22
1TWD
'23
2TWD
'24
3TWD
'25
Ex-udbytte-dato21. aug. 2025
Udbytteafkast5,86%

Analytikerskøn

Baseret på 1 analytiker

Stærkt købKøbHoldSælgStærkt sælg
100%0%0%0%0%